Details for 2009793413

Up to date per 05.04.2026

Actions

Title / Product Name

HEMIFUMARATSALZ VON 1-[4-[1-(4-CYCLOHEXYL-3-TRIFLUORMETHYLBENZYLOXYIMINO)ETHYL]-2-ETHYLBENZYL]AZETIDIN-3-CARBONSÄURE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2009793413

EP Publication Number

2379497

E-Number

627988

Language

PCT Number

US09068143

Publication Date

26.10.2011 A

21.08.2013 B1

Registration Date

21.08.2013

AT Publication Date

15.09.2013

Application Date

16.12.2009

Registration Number

Priorities

18.12.2008

203053 P

IPC

C07D 205/04 20060101AFI20100730BHEP

Maximum Duration of Protection

16.12.2029

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

Schwarz & Partner Patentanwälte OGWipplingerstraße 301010 WienAT

Inventor

CISZEWSKI, LechNovartis One Health Plaza East Hanover, New Jersey 07936US

DE LA CRUZ, MarilynNovartis One Health Plaza East Hanover, New Jersey 07936US

KARPINSKI, Piotr H.Novartis One Health Plaza East Hanover, New Jersey 07936US

MUTZ, MichaelNovartis Pharma AG Postfach CH-4002 BaselCH

RIEGERT, ChristianNovartis Pharma AG Postfach CH-4002 BaselCH

VOGEL, CasparNovartis Pharma AG Postfach CH-4002 BaselCH

SCHNEEBERGER, RicardoNovartis Pharma AG Postfach CH-4002 BaselCH

Information about Fees